OTC · Drug Manufacturers - Specialty & Generic

Invictus MD Strategies Corp. (IVITF) Stock

$0.00 OTC: IVITF Healthcare

Invictus MD Strategies Corp. is a Canadian firm primarily focused on strategic investments, acquisitions, and the development of complementary enterprises within the country's cannabis sector.

Valuation

MetricValue
Price$0.00
Market Cap$4.45M
P/E Ratio0.00
P/B Ratio0.05
P/S Ratio1.11
EPS (TTM)$-0.35
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-30.68%
ROA-23.08%
ROCE-22.47%
Gross Margin-600.00%
Operating Margin-625.00%
Net Margin-675.00%
Debt/Equity0.11
Current Ratio2.86

Annual Financials (USD)

Metric20142015201620172018
Revenue$0$3.0M$2.0M$2.0M$4.0M
Operating Profit$0$-1.0M$-4.0M$-15.0M$-25.0M
Net Profit$-1.0M$0$-4.0M$-16.0M$-27.0M
EPS$-0.83$-0.18$-0.41$-0.24$-0.35
Op Margin—-26.4%-209.6%-759.4%-694.6%

Balance Sheet (USD)

Metric20142015201620172018
Total Assets$0$8.0M$15.0M$94.0M$117.0M
Total Liabilities$0$2.0M$2.0M$10.0M$28.0M
Cash$0$0$0$14.0M$5.0M
Borrowings$0$1.0M$0$0$10.0M

Latest News

3 Value Stocks We Find Risky StockStory · Aug 3, 2026 Marmot Researchers Turn to OnlyFans for Funding—And There Are Meme Coins Too decrypt · Aug 3, 2026 ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND, INC. ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. RESULTS OF SPECIAL MEETING OF STOCKHOLDERS PR Newswire · Aug 3, 2026 Fritz outguns Jodar to win ATP Washington title AFP · Aug 3, 2026 Investing in the "Magnificent Seven?" Pick Your Poison: Negative Free Cash Flow or an Unjustifiable Valuation. Motley Fool · Aug 3, 2026

Cash Flow (USD)

Metric20142015201620172018
Operating Cash Flow$0$-1.0M$-2.0M$-7.0M$-14.0M
Investing Cash Flow$0$-1.0M$-7.0M$-9.0M$-57.0M
Financing Cash Flow$0$0$0$13.0M$32.0M
Net Cash Flow$0$0$0$37.0M$-28.0M
Free Cash Flow$0$-1.0M$-2.0M$-10.0M$-35.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.36
FCF Yield-558.37%
Quick Ratio2.65
Interest Coverage-102.37
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Invictus MD Strategies Corp.

Invictus MD Strategies Corp. is a Canadian firm primarily focused on strategic investments, acquisitions, and the development of complementary enterprises within the country's cannabis sector. The company's operations are divided into two main areas: cannabis sales and fertilizers. Its cannabis division is involved in the cultivation and distribution of medical cannabis. Concurrently, its fertilizer segment offers hydroponic plant fertilizers, nutrient solutions, and various other supplies essential for cultivation. Additionally, Invictus MD Strategies Corp. manages medical clinics situated in Alberta. The company was established in 2014 and maintains its principal office in Vancouver, Canada.

Invictus MD Strategies Corp. (IVITF) stock trades at $0.00 with a market capitalization of $4.45M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.05, price-to-sales of 1.11. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Invictus MD Strategies Corp. generates a return on equity (ROE) of -30.68%, return on capital employed of -22.47%, an operating margin of -625.00%, a net profit margin of -675.00%.

Official website: jet77jkt.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides